ObjectiveTo quantify inequalities in zoster vaccine uptake by determining its association with socio-demographic factors: age, gender, ethnicity, immigration status, deprivation (at Lower-layer Super Output Area-level), care home residence and living arrangements.MethodThis population-based cohort study utilised anonymised primary care electronic health records from England (Clinical Practice Research Datalink) linked to deprivation and hospitalisation data. Data from 35,333 individuals from 277 general practices in England and eligible for zoster vaccination during the two-year period (2013–2015) after vaccine introduction were analysed. Logistic regression was used to obtain adjusted odds ratios (aOR) for the association of socio-demograp...
Objective To examine inequalities in COVID-19 vaccination rates among elderly adults in England. D...
Background Herpes zoster (HZ) is a common condition that increases in incidence with older age bu...
BackgroundThere are known socioeconomic inequalities in annual seasonal influenza (flu) vaccine upta...
ObjectiveTo quantify inequalities in zoster vaccine uptake by determining its association with socio...
BACKGROUND: Zoster vaccination was introduced in England in 2013, where tackling health inequalities...
Background The UK began an ambitious COVID-19 vaccination programme on 8 December 2020. This study d...
Objective: To examine inequalities in COVID-19 vaccination rates among elderly adults in England. D...
BACKGROUND: In the UK, payments to providers (General Practitioners) for vaccinating all people aged...
Objectives: To assess the impact of herpes zoster vaccination in the 5 years after introduction for ...
OBJECTIVE: To examine inequalities in COVID-19 vaccination rates among elderly adults in England. DE...
Vaccination has proven to be effective at preventing severe outcomes of COVID-19 infection, and upta...
BackgroundCOVID-19 vaccine uptake is lower amongst most minority ethnic groups compared to the White...
Vaccination has proven to be effective at preventing severe outcomes of COVID-19 infection, and upta...
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged...
BackgroundThe recombinant zoster vaccine had over 90% efficacy in preventing herpes zoster in clinic...
Objective To examine inequalities in COVID-19 vaccination rates among elderly adults in England. D...
Background Herpes zoster (HZ) is a common condition that increases in incidence with older age bu...
BackgroundThere are known socioeconomic inequalities in annual seasonal influenza (flu) vaccine upta...
ObjectiveTo quantify inequalities in zoster vaccine uptake by determining its association with socio...
BACKGROUND: Zoster vaccination was introduced in England in 2013, where tackling health inequalities...
Background The UK began an ambitious COVID-19 vaccination programme on 8 December 2020. This study d...
Objective: To examine inequalities in COVID-19 vaccination rates among elderly adults in England. D...
BACKGROUND: In the UK, payments to providers (General Practitioners) for vaccinating all people aged...
Objectives: To assess the impact of herpes zoster vaccination in the 5 years after introduction for ...
OBJECTIVE: To examine inequalities in COVID-19 vaccination rates among elderly adults in England. DE...
Vaccination has proven to be effective at preventing severe outcomes of COVID-19 infection, and upta...
BackgroundCOVID-19 vaccine uptake is lower amongst most minority ethnic groups compared to the White...
Vaccination has proven to be effective at preventing severe outcomes of COVID-19 infection, and upta...
Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged...
BackgroundThe recombinant zoster vaccine had over 90% efficacy in preventing herpes zoster in clinic...
Objective To examine inequalities in COVID-19 vaccination rates among elderly adults in England. D...
Background Herpes zoster (HZ) is a common condition that increases in incidence with older age bu...
BackgroundThere are known socioeconomic inequalities in annual seasonal influenza (flu) vaccine upta...